APOB and hepatoblastoma: Approximately half of PMM2-CDG patients exhibit abnormalities in lipid metabolism (6, 9, 38), most commonly primary hypobetalipoproteinemia (HBL), which is characterized by low plasma levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDLc) and apolipoprotein B (apoB) (51).